ETS1 and breast cancer: Our findings align with previous reports that an inhibition of MAPK reduced the phosphorylation and activation of ETS1 in human cholangiocytes23 and breast cancer cells25 and that ERK2‐mediated phosphorylation of ETS1 enhances its binding to CREB‐binding protein.22